Episode 501: MJA Podcasts 2022 Episode 43: New hope for resistant hypertension, with Prof Markus Schlaich

from The Medical Journal of Australia · host theMJA

Vol 217, Issue 11: 28 November 2022. Professor Markus Schlaich is Director of the Dobney Hypertension Centre in Perth, and Dobney Chair of Clinical Research at the University of Western Australia. His recently published research on dual endothelin antagonist aprocitentin for resistant hypertension can be found at The Lancet. His op-ed for InSight+ is free to access and can be found here. With MJA news and online editor Cate Swannell.

Episode metadata supplied by the publisher feed · Published Nov 27, 2022

Embed this episode

Attribution link and audio player

Ready to play

Episode 501: MJA Podcasts 2022 Episode 43: New hope for resistant hypertension, with Prof Markus Schlaich

0:00 23:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Medical Journal of Australia?

This episode is 23 minutes long.

When was this The Medical Journal of Australia episode published?

This episode was published on November 27, 2022.

Can I download this The Medical Journal of Australia episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!